000 04949cam a2200577Mi 4500
001 9781003029915
003 FlBoTFG
005 20220711212051.0
006 m o d
007 cr |n|||||||||
008 210201s2021 flu ob 001 0 eng d
040 _aOCoLC-P
_beng
_cOCoLC-P
020 _a9781000333039
_q(electronic bk.)
020 _a1000333035
_q(electronic bk.)
020 _a9781000333176
_q(ePub ebook)
020 _a1000333175
020 _a9781003029915
_q(ebook)
020 _a1003029914
020 _a9781000333107
_q(electronic bk. : Mobipocket)
020 _a1000333108
_q(electronic bk. : Mobipocket)
020 _z9780367466053
020 _z0367466058
024 7 _a10.1201/9781003029915
_2doi
035 _a(OCoLC)1235761973
035 _a(OCoLC-P)1235761973
050 4 _aTP1180.D45
072 7 _aSCI
_x010000
_2bisacsh
072 7 _aMED
_x071000
_2bisacsh
072 7 _aSCI
_x089000
_2bisacsh
072 7 _aTDCW
_2bicssc
082 0 4 _a615.6
_223
245 0 0 _aDendrimers nanomedicine
_h[electronic resource] :
_bconcept, theory and regulatory perspectives /
_cedited by Neelesh Kumar Mehra and Keerti Jain.
250 _aFirst edition.
264 1 _aBoca Raton :
_bCRC Press,
_c2021.
300 _a1 online resource
336 _atext
_2rdacontent
336 _astill image
_2rdacontent
337 _acomputer
_2rdamedia
338 _aonline resource
_2rdacarrier
520 _aDendrimers, hyperbranched macromolecules, emerged just few decades ago but show promising potential as drug delivery nanocarriers, theranostic agents and gene vectors; in the pharmaceutical research and innovation area as well as in other healthcare applications. Although tremendous advancements have been made in dendrimer chemistry and their applications since their emergence, the synthesis, development and design of pure and safe dendrimer-based products have been a major challenge in this area. This book, edited by well-known researchers in the area of nanomaterials and drug-based drug delivery applications, exhaustively covers the nanotechnological aspects, concepts, properties, characterisation, application, biofate and regulatory aspects of dendrimers. It includes sixteen vivid chapters by renowned formulators, researchers and academicians from all over the world, highlighting their specialised areas of interest in the fields of chemistry, biology, pharmacy and nanomedicine. Features: Highlights dendrimers' advancements in nanomedicine in the development of safe healthcare and biotechnological products Covers physicochemical aspects, biofate, drug delivery aspects and gene therapy using dendrimers Covers biomedical application of dendrimers in the field of biological sciences Gives examples of dendrimer-guest interaction chemistry Dendrimers in Nanomedicine: Concept, Theory and Regulatory Perspectives provides the comprehensive overview of the latest research efforts in designing, optimising, development and scale-up of dendrimer-mediated delivery systems. It analyses the key challenges of synthesis, design, molecular modelling, fundamental concepts, drug delivery aspects, analytical tools and biological fate as well as regulatory consideration to the practical use of dendrimer application. Dr. Neelesh Kumar Mehra Assistant Professor of Pharmaceutics in the Department of Pharmaceutics at the National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad, India. He has authored more than sixty peer-reviewed publications in highly reputed international journals, as well as book chapters and contributions on two patents. Dr. Mehra has 11 years of rich research and teaching experience in the formulation and development of complex, innovative biopharmaceutical products including micro- and nanotechnologies for regulated markets. Dr. Keerti Jain Assistant Professor of Pharmaceutics in the Department of Pharmaceutics, NIPER, Raebareli, India. For more than 10 years, she has been actively engaged in formulation and development of nanomedicines. Dr. Jain has supervised masters and doctoral pharmaceutics students in their research works which have been published in high quality, good impact factor journals. She has also authored more than 60 international manuscripts in peer reviewed high impact journals. In 2019, she was awarded the prestigious ICMR-Amir Shakuntala Award.
588 _aOCLC-licensed vendor bibliographic record.
650 0 _aDendrimers.
_912820
650 0 _aNanoscience.
_910727
650 7 _aSCIENCE / Biotechnology
_2bisacsh
_912821
650 7 _aMEDICAL / Pharmacology
_2bisacsh
_97291
700 1 _aMehra, Narinder K.
_q(Narinder Kumar),
_d1949-
_eeditor.
_912822
700 1 _aJain, Keerti,
_eeditor.
_912823
856 4 0 _3Taylor & Francis
_uhttps://www.taylorfrancis.com/books/9781003029915
856 4 2 _3OCLC metadata license agreement
_uhttp://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf
942 _cEBK
999 _c70301
_d70301